These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25810489)

  • 1. How I treat priapism.
    Anele UA; Le BV; Resar LM; Burnett AL
    Blood; 2015 Jun; 125(23):3551-8. PubMed ID: 25810489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights of priapism mechanism and rationale treatment for recurrent priapism.
    Yuan J; Desouza R; Westney OL; Wang R
    Asian J Androl; 2008 Jan; 10(1):88-101. PubMed ID: 18087648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape.
    Musicki B; Burnett AL
    Expert Opin Ther Targets; 2020 May; 24(5):439-450. PubMed ID: 32191546
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular pathophysiology of priapism: emerging targets.
    Anele UA; Morrison BF; Burnett AL
    Curr Drug Targets; 2015; 16(5):474-83. PubMed ID: 25392014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.
    Anele UA; Burnett AL
    J Sex Med; 2015 Mar; 12(3):713-9. PubMed ID: 25572153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy.
    Broderick GA
    J Sex Med; 2012 Jan; 9(1):88-103. PubMed ID: 21699659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.
    Bivalacqua TJ; Musicki B; Hsu LL; Gladwin MT; Burnett AL; Champion HC
    J Sex Med; 2009 Sep; 6(9):2494-504. PubMed ID: 19523035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of ischemic stuttering priapism: a contemporary review of the literature.
    Levey HR; Kutlu O; Bivalacqua TJ
    Asian J Androl; 2012 Jan; 14(1):156-63. PubMed ID: 22057380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stuttering priapism: insights into pathogenesis and management.
    Morrison BF; Burnett AL
    Curr Urol Rep; 2012 Aug; 13(4):268-76. PubMed ID: 22648304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm.
    Joice GA; Liu JL; Burnett AL
    BJU Int; 2021 May; 127(5):498-506. PubMed ID: 33606327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway.
    Claudino MA; Franco-Penteado CF; Corat MA; Gimenes AP; Passos LA; Antunes E; Costa FF
    J Sex Med; 2009 Aug; 6(8):2187-96. PubMed ID: 19493282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Ischemic Priapism: An AUA/SMSNA Guideline.
    Bivalacqua TJ; Allen BK; Brock G; Broderick GA; Kohler TS; Mulhall JP; Oristaglio J; Rahimi LL; Rogers ZR; Terlecki RP; Trost L; Yafi FA; Bennett NE
    J Urol; 2021 Nov; 206(5):1114-1121. PubMed ID: 34495686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions.
    Pereira DA; Calmasini FB; Costa FF; Burnett AL; Silva FH
    J Pharmacol Exp Ther; 2024 Jul; 390(2):203-212. PubMed ID: 38262744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis.
    Lagoda G; Sezen SF; Cabrini MR; Musicki B; Burnett AL
    J Urol; 2013 Feb; 189(2):762-8. PubMed ID: 22982429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penile Doppler ultrasound in men with stuttering priapism and sickle cell disease -- a labile baseline diastolic velocity is a characteristic finding.
    Patel U; Sujenthiran A; Watkin N
    J Sex Med; 2015 Feb; 12(2):549-56. PubMed ID: 25424427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using cyproterone acetate to treat recurrent ischemic priapism in a patient with sickle cell anemia as a comorbidity: a case report.
    Alshahrani A
    J Med Case Rep; 2020 Oct; 14(1):197. PubMed ID: 33081822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of SCD-Related Priapism With Crizanlizumab: A Case Series.
    Idowu M; Garcia RL; Sule OB
    J Investig Med High Impact Case Rep; 2023; 11():23247096231191873. PubMed ID: 37731262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA Guideline.
    Bivalacqua TJ; Allen BK; Brock GB; Broderick GA; Chou R; Kohler TS; Mulhall JP; Oristaglio J; Rahimi LL; Rogers ZR; Terlecki RP; Trost L; Yafi FA; Bennett NE
    J Urol; 2022 Jul; 208(1):43-52. PubMed ID: 35536142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine signaling, priapism and novel therapies.
    Dai Y; Zhang Y; Phatarpekar P; Mi T; Zhang H; Blackburn MR; Xia Y
    J Sex Med; 2009 Mar; 6 Suppl 3():292-301. PubMed ID: 19267852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High flow priapism associated with sickle cell disease.
    Ramos CE; Park JS; Ritchey ML; Benson GS
    J Urol; 1995 May; 153(5):1619-21. PubMed ID: 7714988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.